|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002996,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0038257,
umls-concept:C0155626,
umls-concept:C0205225,
umls-concept:C0332293,
umls-concept:C0333186,
umls-concept:C0522523,
umls-concept:C0936012,
umls-concept:C1444754,
umls-concept:C1511726,
umls-concept:C1516048,
umls-concept:C1522318,
umls-concept:C1524063,
umls-concept:C1527178,
umls-concept:C1705938,
umls-concept:C1948041,
umls-concept:C2350591,
umls-concept:C2919090
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-6-16
|
|
pubmed:abstractText |
Stent length is a major predictor of restenosis in stable patients undergoing percutaneous coronary intervention (PCI) with bare metal stents (BMS). The effect of stent length is decreased by using drug eluting stents, however, this association had not been previously determined in patients with acute myocardial infarction (AMI). We sought to determine the impact of stent length on restenosis in patients who undergo primary PCI for AMI.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1969-6213
|
|
pubmed:author |
pubmed-author:BodeChristophC,
pubmed-author:CebrianAnaA,
pubmed-author:HenryPatrickP,
pubmed-author:KriviskiMichaelM,
pubmed-author:RozenmanYosephY,
pubmed-author:SpauldingChristianC,
pubmed-author:StollHans-PeterHP,
pubmed-author:TamariIsraelI,
pubmed-author:TeigerEmmanuelE,
pubmed-author:TurkisherVladimirV,
pubmed-author:WitzlingValentinV
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
219-23
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19527979-Aged,
pubmed-meshheading:19527979-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19527979-Cardiovascular Agents,
pubmed-meshheading:19527979-Coronary Angiography,
pubmed-meshheading:19527979-Coronary Restenosis,
pubmed-meshheading:19527979-Coronary Stenosis,
pubmed-meshheading:19527979-Drug-Eluting Stents,
pubmed-meshheading:19527979-Europe,
pubmed-meshheading:19527979-Female,
pubmed-meshheading:19527979-Humans,
pubmed-meshheading:19527979-Israel,
pubmed-meshheading:19527979-Male,
pubmed-meshheading:19527979-Metals,
pubmed-meshheading:19527979-Middle Aged,
pubmed-meshheading:19527979-Myocardial Infarction,
pubmed-meshheading:19527979-Prosthesis Design,
pubmed-meshheading:19527979-Risk Assessment,
pubmed-meshheading:19527979-Risk Factors,
pubmed-meshheading:19527979-Severity of Illness Index,
pubmed-meshheading:19527979-Single-Blind Method,
pubmed-meshheading:19527979-Sirolimus,
pubmed-meshheading:19527979-Stents,
pubmed-meshheading:19527979-Time Factors,
pubmed-meshheading:19527979-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
|
|
pubmed:affiliation |
Heart Institute, E. Wolfson Medical Center, Holon, Israel. rozenman@wolfson.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
